These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25299749)

  • 21. Health disparities among African-American and Hispanic drug injectors--HIV, AIDS, hepatitis B virus and hepatitis C virus: a review.
    Estrada AL
    AIDS; 2005 Oct; 19 Suppl 3():S47-52. PubMed ID: 16251828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.
    Williams LD; Mackesy-Amiti ME; Latkin C; Boodram B
    Drug Alcohol Depend; 2021 Apr; 221():108626. PubMed ID: 33689967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users.
    Trenz RC; Scherer M; Harrell P; Zur J; Sinha A; Latimer W
    Addict Behav; 2012 Apr; 37(4):367-72. PubMed ID: 22172686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of race and age with treatment attendance and completion among adult marijuana users in community-based substance abuse treatment.
    Peters EN; Hendricks PS; Clark CB; Vocci FJ; Cropsey KL
    J Addict Med; 2014; 8(2):143-9. PubMed ID: 24603621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injection drug use, unknown HIV positive status, and self-reported current PrEP use among Black men who have sex with men attending U.S. Black pride events, 2014-2017.
    Maksut JL; Gicquelais RE; Jackman KM; Eaton LA; Friedman MR; Matthews DD; Bukowski LA; Stall RD
    Drug Alcohol Depend; 2020 Feb; 207():107808. PubMed ID: 31855657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants.
    Smith BD; Jewett A; Burt RD; Zibbell JE; Yartel AK; DiNenno E
    J Infect Dis; 2013 Dec; 208(12):1934-42. PubMed ID: 24136794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
    Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017.
    Bull-Otterson L; Huang YA; Zhu W; King H; Edlin BR; Hoover KW
    J Infect Dis; 2020 Aug; 222(6):940-947. PubMed ID: 32002537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
    Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
    Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in HIV and hepatitis C related vulnerabilities among aboriginal young people who use street drugs in two Canadian cities.
    ; Mehrabadi A; Paterson K; Pearce M; Patel S; Craib KJ; Moniruzzaman A; Schechter MT; Spittal PM
    Women Health; 2008; 48(3):235-60. PubMed ID: 19191041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999.
    Santibanez SS; Garfein RS; Swartzendruber A; Kerndt PR; Morse E; Ompad D; Strathdee S; Williams IT; Friedman SR; Ouellet LJ
    Drug Alcohol Depend; 2005 Mar; 77(3):227-33. PubMed ID: 15734222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in blood-borne infection risk among injection drug users.
    Mehta SH; Astemborski J; Kirk GD; Strathdee SA; Nelson KE; Vlahov D; Thomas DL
    J Infect Dis; 2011 Mar; 203(5):587-94. PubMed ID: 21282191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.